JAVA - Short squeeze Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : JAVA - Short squeeze

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Beermeister who wrote (90)	10/3/1997 7:56:00 PM
From: Richard Mazzarella	of 157

Daryn, I will not suggest what others should do. You are absolutely correct in not being able to dope out the value of this deal until someone at JAVA tells us. Even then, I'm not sure I would believe anything management says. Look at the runaround they gave Sam. However at some point we should be able to value the medical company. Until then, I will hold my stock. If I didn't own JAVA, I would buy it. Unless Tri-Star is simply a scam, I could see JAVA trading back at $1-2 with the current number of shares (pre split). There could be an effort now to reverse split the stock to get the valuation of the stock up to where the medical activity would qualify for NASDAQ. The comment about the spin-off of the coffee business to shareholders is also interesting. We could even end up with two different stocks when we started with one. The whole play seems to be getting a private medical company public at very little cost. There is still much to be learned and all my comments should be taken as conjecture because I have no special knowledge. However, the speculation is sure fun.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next